NFE2L2 and central nervous system cancer: In addition, triptolide and brusatol, as NRF2 inhibitors, suppresses potently IDH1-mutated glioma cells by targeting the NRF2-driven glutathione synthesis pathway to induce lipid peroxidation [92,93].